Clinical Trial Results:
A phase II, randomized, double-blind, placebo controlled, multi-center study to evaluate the effects of LCI699 on cortisol in patients with hypertension.
Summary
|
|
EudraCT number |
2008-007337-49 |
Trial protocol |
IS |
Global completion date |
12 Aug 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1 |
This version publication date |
17 May 2018
|
First version publication date |
17 May 2018
|
Other versions |
v2 |
Summary report(s) |
CLCI699A2215 NVS CTR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.